Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets ...

Bristol Myers forecasts steeper drop in 2025 revenue, shares fall Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic ...

Bristol-Myers Squibb Company Profile ( Get Free Report Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Bristol-Myers Squibb Company  (NYSE:BMY) declares $0.62/share quarterly dividend, in line with previous. Forward yield 4.14% Payable May 1; for shareholders of record April 4; ex-div April 4. The ...

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Bristol Myers Squibb said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to chart a path toward long-term growth. The company also issued full ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best wide moat stocks to invest in. Russell Investments continues to monitor and ...

US-based pharmaceutical company Bristol Myers Squibb (BMS ... "Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial" was originally created and published by Clinical ...

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s shares closed yesterday at $54.98. See what stocks ...